3.8 Article

Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging mice

Journal

NPJ AGING AND MECHANISMS OF DISEASE
Volume 7, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41514-021-00076-5

Keywords

-

Funding

  1. Saint Louis University
  2. NIH [NS108138, NS103094]
  3. PSC-CUNY Award - City University of New York
  4. Common Fund of the Office of the Director of the National Institutes of Health
  5. NCI
  6. NHGRI
  7. NHLBI
  8. NIDA
  9. NIMH
  10. NINDS
  11. Clinical Nutrition Research Unit Center [1P30 DK072476]
  12. National Institutes of Health through the NIDDK
  13. NCI Cancer Center Support Grant [P30 CA91842]
  14. ICTS/CTSA [UL1TR002345]
  15. National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)
  16. NIH Roadmap for Medical Research

Ask authors/readers for more resources

Studies have shown that adropin is highly expressed in the human brain and plays a crucial role in neural network development and function. In elderly individuals, adropin is positively correlated with genes related to mitochondrial function, morphogenesis, and inflammation, while cognitive decline can be reversed by increasing adropin expression.
The neural functions of adropin, a secreted peptide highly expressed in the brain, have not been investigated. In humans, adropin is highly expressed in astrocytes and peaks during critical postnatal periods of brain development. Gene enrichment analysis of transcripts correlating with adropin expression suggests processes relevant to aging-related neurodegenerative diseases that vary with age and dementia state, possibly indicating survivor bias. In people aged <40 y and 'old-old' (>75 y) diagnosed with dementia, adropin correlates positively with genes involved in mitochondrial processes. In the 'old-old' without dementia adropin expression correlates positively with morphogenesis and synapse function. Potent neurotrophic responses in primary cultured neurons are consistent with adropin supporting the development and function of neural networks. Adropin expression in the 'old-old' also correlates positively with protein markers of tau-related neuropathologies and inflammation, particularly in those without dementia. How variation in brain adropin expression affects neurological aging was investigated using old (18-month) C57BL/6J mice. In mice adropin is expressed in neurons, oligodendrocyte progenitor cells, oligodendrocytes, and microglia and shows correlative relationships with groups of genes involved in neurodegeneration and cellular metabolism. Increasing adropin expression using transgenesis improved spatial learning and memory, novel object recognition, resilience to exposure to new environments, and reduced mRNA markers of inflammation in old mice. Treatment with synthetic adropin peptide also reversed age-related declines in cognitive functions and affected expression of genes involved in morphogenesis and cellular metabolism. Collectively, these results establish a link between adropin expression and neural energy metabolism and indicate a potential therapy against neurological aging.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available